GlycoCURE Discovery is an interdisciplinary VIPR team focused on harnessing drug discovery and glycobiology to develop new disease models and therapeutic approaches for treating rare disease, with particular focus on congenital disorders of glycosylation (CDGs). Approximately 30 million individuals in the United States are living with a rare disease, which by definition have a prevalence of […]
